Trial
NCT02779192
A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Sound Pharmaceuticals, Incorporated
Collaborators
—
Condition
Noise Induced Hearing Loss
Intervention
SPI-1005 200mg
Why stopped
Study did not start
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-03